公司資料
Infinity Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- INFI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for INFI.
公司概覽
業務概覽
Infinity Pharmaceuticals was an oncology company focused on immuno-oncology and targeted cancer programs before becoming a legacy biotech ticker. Its story was defined by the difficulty of sustaining momentum in a crowded oncology market.
所在地與產業分類
Infinity was headquartered in the United States and listed on NASDAQ. It sat in small-cap oncology biotechnology.
商業模式特徵
The business depended on clinical data, strategic updates, and capital efficiency while advancing a narrow pipeline. Investors historically watched whether the company could produce differentiated cancer assets.
生技產業定位
Infinity is best viewed as a historical oncology biotech name. It belongs to the category of small-cap companies where scientific promise was often not enough without capital and execution.
未來催化劑
- Infinity Pharmaceuticals is now a legacy / closeout story, so the catalysts are any residual asset or corporate-resolution update. There is no broad live pipeline left.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。